A new synthetic derivative of cryptotanshinone KYZ3 as STAT3 inhibitor for triple-negative breast cancer therapy

Silencing STAT3 is confirmed as a promising therapeutic strategy for triple-negative breast cancer (TNBC) therapy to address the issue of its poor prognosis. In this study, the natural product cryptotanshinone was firstly remodeled and modified as a more effective STAT3 inhibitor by structure-based...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Wenda, Yu, Wenying, Cai, Guiping, Zhu, Jiawen, Zhang, Chao, Li, Shanshan, Guo, Jianpeng, Yin, Guoping, Chen, Chen, Kong, Lingyi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6204138/
https://www.ncbi.nlm.nih.gov/pubmed/30368518
http://dx.doi.org/10.1038/s41419-018-1139-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6204138/
https://www.ncbi.nlm.nih.gov/pubmed/30368518
http://dx.doi.org/10.1038/s41419-018-1139-z

Ejemplares similares